KRM22’s Keith Todd discusses their new partnership with Kintail Consulting, launching the People & Culture Risk Management solution, customers they are specifically targeting and why they chose Kintail Consulting to...
N4 Pharma’s Nigel Theobald discusses final results, updates on the three work streams, the European patent for Nuvec & what this means for the company and what investors can expect...
Serinus Energy’s Jeffrey Auld discusses the production results from the M1008 well, any challenges created by COVID, the next steps to bring the well onto production and plans for the...
Zotefoams’ David Stirling discusses commencing production at their new plant in Poland, how they will increase flexibility and responsiveness, what will be produced at the new plant and what the...
Sativa Wellness Group’s Geremy Thomas discusses board changes, submitting the novel food application to the FSA and the recent success of new listings in their sector in this exclusive interview...
Path Investments’ Christopher Theis discusses the £3.5 million fundraise, what the proceeds will be used for and what investors should know about the company in this exclusive interview with DirectorsTalk.
Sativa Wellness Group’s Geremy Thomas discusses the roll out of more testing facilities, how long this will last for and developing new wellness activities going forward in this exclusive interview...
Diverse Income Trust’s Gervais Williams discusses the main factors that have driven the returns, sustaining revenue per share, the UK stock market and finding new holdings on attractive valuations in...